bibliographicCitation |
Jiang W, Yang Z, Chen P, Zhao M, Wang Y, Wang J, Li X, Wang M, Hou P. Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1. Expert Opinion on Therapeutic Targets. 2023 Sep 02;27(9):879–95. doi: 10.1080/14728222.2023.2259097. |